Bolognia JL, Pawelek JM. Biology of hypopigmentation. J Am Acad Dermatol. 1988;19:217–55.
Lerner AB. Vitiligo. J Invest Dermatol. 1959;32:285–310.
Lerner AB, Nordlund JJ. Vitiligo. What is it? Is it important? JAMA. 1978;239:1183–7.
Fitzpatrick TB. The scourge of vitiligo. Fitzpatrick’s J Clin Dermatol. 1993;1:68–9.
Parsad D, Dogra S, Kanwar AJ. Quality of life in patients with vitiligo. Health Qual Life Outcomes. 2003;1:58.
Porter JR, Beuf AH, Nordlund JJ, Lerner AB. Personal responses to vitiligo. Arch Dermatol. 1978;114:1348–85.
Porter JR, Beuf AH, Nordlund JJ, Lerner AB. Psychological reaction to chronic skin disorders. A study of patients with vitiligo. Gen Hosp Psychiatry. 1979;1:73–7.
Porter J, Beuf A, Lerner A, et al. The effect of vitiligo on sexual relationship. J Am Acad Dermatol. 1990;22:221–2.
Salzer B, Schallreuter K. Investigations of the personality structure in patients with vitiligo and a possible association with catecholamine metabolism. Dermatology. 1995;190:109–15.
Schmid-Ott G, Kunsebeck HW, Jecht E, Shimshoni R, et al. Stigmatization experience, coping and sense of coherence in vitiligo patients. J Eur Acad Dermatol Venereol. 2007;21:456–61.
Savin J. The hidden face of dermatology. Clin Exp Dermatol. 1993;18:393–5.
Mattoo SK, Handa S, Kaur I, et al. Psychiatric morbidity in vitiligo: prevalence and correlates in India. J Eur Acad Dermatol Venereol. 2002;16:573–8.
Ginsburg IH. The psychological impact of skin diseases: an overview. Dermatol Clin. 1996;14:473–84.
Cotterill JA, Cunliffe WJ. Suicide in dermatological patients. Br J Dermatol. 1997;137(2):246–50.
Hill-Beuf A, Porter JDR. Children coping with impared appearance. Social and psychologic influences. Gen Hosp Psychiatry. 1984;6:294–300.
Kent G, Al’ Abadie M. Factors affecting responses on dermatology life quality index items among vitiligo sufferers. Clin Exp Dermatol. 1996;21:330–3.
Al’Abadie MSK, Kent G, Gawkrodger DJ. The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol. 1994;130:199–203.
Tu C, Zhao D, Lin X. Levels of neuropeptide-Y in the plasma and skin tissue fluids of patients with vitiligo. J Dermatol Sci. 2001;27:178–82.
Liu PY, Bondesson L, Löntz W, Johansson O. The occurrence of cutaneous nerve endings and neuropeptides in vitiligo vulgaris: a case-control study. Arch Dermatol Res. 1996;288:670–5.
Picardi A, Pasquini P, Cattaruzza MS, et al. Stressful life events, social support, attachment security and alexithymia in vitiligo. A case-control study. Psychother Psychosom. 2003;72:150–8.
Parsad D, Pandhi R, Dogra S, et al. Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome. Br J Dermatol. 2003;148:373–4.
Krishna GS, Ramam M, Mehta M, Sreenivas V, Sharma VK, Khandpur S. Vitiligo impact scale: an instrument to assess the psychosocial burden of vitiligo. Indian J Dermatol Venereol Leprol. 2013;79:205–10.
Gupta V, Sreenivas V, Mehta M, Khaitan BK, Ramam M. Measurement properties of the Vitiligo Impact Scale-22 (VIS-22), a vitiligo-specific quality-of-life instrument. Br J Dermatol. 2014;171:1084–90.
Gupta V, Sreenivas V, Mehta M, Ramam M. What do Vitiligo Impact Scale-22 scores mean? Studying the clinical interpretation of scores using an anchor-based approach. Br J Dermatol. 2018.
Lilly E, Lu PD, Borovicka JH, Victorson D, Kwasny MJ, West DP, et al. Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL). J Am Acad Dermatol. 2013;69:e11–8.
Catucci Boza J, Giongo N, Machado P, Horn R, Fabbrin A, Cestari T. Quality of life impairment in children and adults with vitiligo: a cross-sectional study based on dermatology-specific and disease-specific quality of life instruments. Dermatology. 2016;232:619–25.
Salzes C, Abadie S, Seneschal J, Whitton M, Meurant J-M, Jouary T, et al. The Vitiligo Impact Patient scale (VIPs): development and validation of a Vitiligo Burden Assessment Tool. J Invest Dermatol. 2016;136:52–8.
Papadopoulos L, Bor R, Legg C. Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behaviour therapy. Br J Med Psychol. 1999;72:385–96.